SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

ProNAi Therapeutics Inc (DNAI)

DNAI RSS Feed
Add DNAI Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor, Sunofwolf
Search This Board:
Last Post: 9/21/2016 2:46:22 PM - Followers: 25 - Board type: Free - Posts Today: 0



A clinical-stage oncology company pioneering a novel class of therapeutics based on our proprietary DNA interference (DNAi®) technology platform.

Their vision is to be the leader in developing and commercializing a portfolio of DNAi-based therapies to deliver extraordinary therapeutic outcomes that dramatically change patients’ lives.

Their lead DNAi product candidate, PNT2258, targets BCL2, a widely overexpressed oncogene that is an important gatekeeper of the programmed cell death process known as apoptosis and has been linked to many forms of cancer. They believe the preliminary evidence of efficacy, safety and tolerability observed to date suggest that PNT2258 has the potential to change treatment paradigms across a wide range of oncology indications. They recently initiated Wolverine, a Phase 2 trial for the treatment of third-line relapsed or refractory DLBCL, and by mid-2015, we plan to initiate Brighton a Phase 2 trial for the treatment of Richter’s.

NEWS RELEASE

ProNAi to Present at Jefferies Autumn 2015 Global Healthcare Conference in London

VANCOUVER, Nov. 11, 2015 /CNW/ - ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company at the Jefferies Autumn 2015 Global Healthcare Conference in London.

The presentation is scheduled for 4:40 pm (GMT) on Thursday, November 19th. A live webcast of the presentation will be accessible through the ProNAi website at www.pronai.com.  An archived replay of the presentation will also be available.

About ProNAi Therapeutics
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi's lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi is actively enrolling patients in "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and in "Brighton", a Phase 2 trial evaluating PNT2258 for the treatment of Richter's transformation. For more information, please visitwww.pronai.com.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding ProNAi's anticipated clinical development activities, including the design, timing and outcome of such activities. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that ProNAi may be unable to successfully develop and commercialize PNT2258 or any other future product candidates, PNT2258 may fail to demonstrate safety and efficacy or may not otherwise produce positive results, ProNAi may experience delays in clinical trials, including due to difficulties enrolling patients, ProNAi's third-party manufacturers may cause its supply of materials to become limited or interrupted or fail to be of satisfactory quantity or quality,
ProNAi's cash resources may be insufficient to fund its current operating plans and it may be unable to raise additional capital when needed, ProNAi may be unable to obtain and enforce intellectual property protection for its technologies and product candidates and the other factors described under the heading "Risk Factors" set forth in ProNAi's filings with the Securities and Exchange Commission from time to time, including the Company's reports filed with the Securities and Exchange Commission. ProNAi undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DNAI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
DNAI News: Confidential Treatment Order (ct Order) 09/09/2016 03:15:24 PM
DNAI News: Quarterly Report (10-q) 08/12/2016 08:14:10 AM
DNAI News: Current Report Filing (8-k) 08/12/2016 08:08:15 AM
DNAI News: ProNAi Therapeutics Reports Second Quarter 2016 Results 08/12/2016 07:00:00 AM
DNAI News: ProNAi Therapeutics Reports Second Quarter 2016 Results 08/12/2016 07:00:00 AM
PostSubject
#259  Sticky Note Very bad fundamental news for DNAI! Giant OS Value_Investor 09/09/16 03:37:32 PM
#123  Sticky Note Article on thestreet.com jesus harold 07/07/16 08:11:27 AM
#265   Understood all the investor's frustrations with this pos Value_Investor 09/16/16 04:53:26 PM
#264   This maybe only a back up plan, but Sunofwolf 09/13/16 08:11:07 AM
#263   If the crap CEO didn't file that bullshit Value_Investor 09/12/16 11:28:47 PM
#262   I have given up on this stock-it just Sunofwolf 09/12/16 06:27:22 PM
#261   This would still have over two dollars in Sunofwolf 09/10/16 07:19:07 PM
#260   Not sure if your right about what the Sunofwolf 09/10/16 02:55:49 PM
#259   Very bad fundamental news for DNAI! Giant OS Value_Investor 09/09/16 03:37:32 PM
#258   Yup, no reason to be down here... PROPHETABLE 09/08/16 03:56:44 PM
#257   DNAI 130 Million in Cash no debt Trading Stockexpertpro 09/08/16 03:54:51 PM
#256   A little bit at a time-We head to $4.50! Sunofwolf 09/07/16 05:55:00 PM
#255   Book value has it at over $4! Sunofwolf 09/06/16 07:03:04 PM
#254   Been movin up all day1 Sunofwolf 09/06/16 03:14:08 PM
#253   I would think News is coming this week! Sunofwolf 09/06/16 09:07:18 AM
#252   the ceo will start batting this month! Sunofwolf 09/02/16 11:43:19 AM
#251   Well maybe we get some News next week! Sunofwolf 09/01/16 04:12:43 PM
#250   I think you are right on that. JeffAdams05 08/31/16 03:25:26 PM
#249   I think its going to turn a corner soon. Sunofwolf 08/31/16 09:11:46 AM
#248   Summer vacation is ending this month-so I think Sunofwolf 08/29/16 06:39:25 PM
#247   Finally back in this one. The low JeffAdams05 08/29/16 03:04:41 PM
#246   Good time to buy-very cheap price. Sunofwolf 08/29/16 02:42:19 PM
#245   News needed! Sunofwolf 08/29/16 11:07:39 AM
#244   Yeah it's stuck in this 1.85-2.10 channel, breaks PROPHETABLE 08/28/16 01:53:54 PM
#243   Really coiled here for the last couple weeks, TradeFlow 08/27/16 06:49:27 PM
#242   Here is why: Our CEO, Dr. Nick Glover PROPHETABLE 08/27/16 03:35:14 PM
#241   Why Sone 08/26/16 09:59:25 PM
#240   Sept is when it takes off! Sunofwolf 08/26/16 09:10:52 PM
#239   It's going 3+ IMO so you're fine PROPHETABLE 08/24/16 04:28:06 PM
#238   In at $1.95 a little too early.. Oh Sone 08/24/16 04:27:38 PM
#237   Added a good amount today... PROPHETABLE 08/24/16 04:13:58 PM
#236   POS lvhd 08/24/16 02:25:24 PM
#235   I agree. Clearly over 3 dollars in Rudy Gobert 08/24/16 11:34:50 AM
#234   Yup...looks like we are on our way PROPHETABLE 08/24/16 11:03:44 AM
#233   Very close! $3.00s soon enough ! blindjohn 08/24/16 10:55:35 AM
#232   DNAI going... lvhd 08/24/16 10:52:23 AM
#231   Should be trading at book value-$4.25! Sunofwolf 08/24/16 08:18:37 AM
#230   Let's get this back over 2 where it Rudy Gobert 08/24/16 06:48:49 AM
#229   She's close, she will be in the cloud soon: investorshub.advfn.com/uimag PROPHETABLE 08/23/16 04:56:31 PM
#228   You are not mistaken, book value on this PROPHETABLE 08/23/16 04:52:48 PM
#227   Unfortunately, that's what it looks like. And I ClearlyStocks 08/23/16 11:29:33 AM
#226   Dilution? lvhd 08/23/16 10:51:41 AM
#225   That's what I see as well...stupid to be PROPHETABLE 08/22/16 06:28:04 PM
#224   $2.07 ClearlyStocks 08/22/16 02:24:10 PM
#223   $2.06 ClearlyStocks 08/22/16 02:15:54 PM
#222   DNAI on top 50sma. Gear up PAC 08/22/16 02:13:33 PM
#221   $2 might pop ClearlyStocks 08/22/16 01:31:58 PM
#220   News needed Sunofwolf 08/21/16 10:00:16 AM
#219   I think your right! Sunofwolf 08/19/16 12:32:50 PM
#218   DNAI 1.90 three months bottom basing. On watch PAC 08/18/16 01:01:42 AM
#217   Churn and Churn WarChest 08/17/16 03:24:36 PM
#216   I love that phase. Almost never get dranesthesia1 08/17/16 08:27:31 AM
PostSubject